Abstract:Objective:To evaluate the efficacy and safety of ibuprofen injection for postoperative analgesia in the patients undergoing general anesthesia.Methods:This prospective, multicenter, randomized, double-blind, negative-controlled trial was conducted in 360 patients of both sexes, aged 18-75 yr, of American Society of Anesthesiologists physical statusⅠ-Ⅲ, scheduled to undergo elective abdominal or orthopedic surgery under general anesthesia.All the patients were assigned to one of 3 groups ( n=120 each) using a random number tale method: control group (group C), ibuprofen injection 400 mg group (group B1), and ibuprofen injection 800 mg group (group B2). At 30 min before the end of surgery, ibuprofen injection 400 and 800 mg (in 0.9% sodium chloride injection 200 ml) were intravenously infused over 30 min in B1 and B2 groups, respectively, and 0.9% sodium chloride injection 200 ml was intravenously infused over 30 min in group C, and then infusion was performed every 6 h until 48 h after operation.The analgesic pump was connected after operation to perform patient-controlled intravenous analgesia (PCIA), and the PCIA solution contained 0.5 mg/ml morphine in 0.9% sodium chloride injection.The PCA pump was set up with a 2 ml bolus dose, a 5 min lockout interval and background infusion at a rate of 0.25 ml/h.The analgesia lasted for 48 h after operation, and the visual analog scale score was maintained ≤ 4 points.Effectiveness index: the consumption of morphine within 24 and 48 h after operation, the total pressing times of PCA and effective pressing times of PCA, the requirement for rescue analgesia within 48 h after operation and patient′s overall evaluation of the analgesia effect at 48 h after operation were recorded.Safety index: the occurrence of adverse reactions (nausea, vomiting, pruritus, injection pain, dizziness, etc.) within 48 h after medication were recorded; the laboratory examinations including blood biochemical examination, blood routine examination, blood coagulation function examination and urine routine examination were performed at 48 h after medication, and abnormal conditions were recorded. Results:Compared with group C, the postoperative consumption of morphine, total pressing times of PCA, effective pressing times of PCA, and requirement for rescue analgesia were significantly decreased, and the rates of excellent and excellent+ good evaluation of analgesic effects by patients were increased in B1 and B2 groups ( P<0.05). There was no significant difference in the parameters mentioned above between B1 group and B2 group ( P>0.05). There was no significant difference in the incidence of nausea, vomiting, pruritus, injection pain and dizziness and rates of abnormalities in laboratory examinations among the three groups ( P>0.05). Conclusion:Ibuprofen injection can be safely and effectively used for postoperative analgesia in the patients undergoing general anesthesia.

Clinical evaluation of analgesic effect and safety of scorpion venom injection

[Effects of Intrathecal Transient Receptor Potential Vanilloid 1 Blocker on Cervical Distension Induced Visceral Pain Response].

Evaluation on postoperative analgesia efficacy of oxycodone combined with dexmedetomidine in patients underwent laparoscopic radical surgery of colon cancer

Pain Management of Patients underwent Transradial Coronary Intervention Therapy

Randomized and Double -Blind Controlled Clinical Trial of Dezocine Injection for Analgesia

Efficacy and safety of ibuprofen injection for postoperative analgesia in patients undergoing general anesthesia: prospective, multicenter, randomized, double-blind, negative-controlled, clinical trial

Scorpion venom peptide, BmK AGAP as an adjuvant to lidocaine in sciatic nerve block causes dose-dependent increase intensity of sensory block and prolog duration of analgesia in rat.

Makatoxin-3, a Thermostable Nav1.7 Agonist from Buthus Martensii Karsch (bmk) Scorpion Elicits Non-Narcotic Analgesia in Inflammatory Pain Models.

Meta-analysis on Randomized Controlled Clinical Trials of Point Injection on Cancer Pain

A RANDOMIZED AND DOUBLE- BLIND CONTROLLED CLINICAL TRIAL OF DIHYDROCODEINE TRATRATE FOR ANALGESIA

Antihyperalgesia Effect of BmK IT2, a Depressant Insect-Selective Scorpion Toxin in Rat by Peripheral Administration

Report of phase Ⅱ clinical trial of APA-BCC_S

Effect of Intrathecal Dexmedetomidine on Spinal Morphine Analgesia in Patients with Refractory Cancer Pain

Evaluation of the Effect of New Multimodal Analgesia Regimen for Cardiac Surgery: A Prospective, Randomized Controlled, Single-Center Clinical Study

Assessing the clinical advantage of opioid-reduced anesthesia in thoracoscopic sympathectomy: a prospective randomized controlled trial

The efficacy and safety of epidural morphine/hydromorphone in the treatment of intractable postherpetic neuralgia: A single-center, double-blinded, randomized controlled, prospective, and non-inferiority study

Effect of Intrathecal Injection JWH015 on the Remifentani-Induced Hyperalgesia in Rats

The effect of buprenorphine combined with bupivacaine for epidural analgesia in patients underwent transurethral resection of the prostate (TURP)

Study on the postoperative analgesic effect of dezocine and sufentanil in patients with colorectal cancer

Randomized and Double-Blind Controlled Clinical Trial of Tilidine Hydrochloride Oral Solution for Analgesia

Comparison of the effects of Valsalva maneuver, EMLA cream, and the combination of both in relieving pain of needle insertion on totally implantable access port: A randomized controlled study